Last updated on October 2017

Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate


Brief description of study

This is an 8 week study to assess the efficacy and safety profile of PF-06651600 in seropositive subjects with rheumatoid arthritis with an inadequate response to methotrexate (up to approximately 50% of subjects may also have had an inadequate response to 1 anti-TNF biologic).

Clinical Study Identifier: NCT02969044

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

LTD "Unimed Ajara" Batumi Referral Hospital
Batumi, Georgia
2.3miles
  Connect »